A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees
- 8 August 2001
- Vol. 19 (32) , 4595-4602
- https://doi.org/10.1016/s0264-410x(01)00260-2
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- An Antimicrobial Activity of Cytolytic T Cells Mediated by GranulysinScience, 1998
- Biology of malarial liver stages: implications for vaccine designPathogens and Global Health, 1998
- In vivo protective anti‐HIV immune responses in non‐human primates through DNA immunizationJournal of Medical Primatology, 1996
- Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy studyParasitology, 1995
- Chimpanzees and supporting models in the study of malaria pre-erythrocytic stagesMemórias do Instituto Oswaldo Cruz, 1994
- Transmission-blocking immunity against malaria and other vector-borne diseasesCurrent Opinion in Immunology, 1993
- Molecular analysis of the association of HLA-B53 and resistance to severe malariaNature, 1992
- Structure of Plasmodium falciparum liver stage antigen-1Molecular and Biochemical Parasitology, 1991
- Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malariaNature, 1989
- Live recombinant vaccinia virus protects chimpanzees against hepatitis BNature, 1984